Literature DB >> 17910944

Brain expression of the calcineurin inhibitor RCAN1 (Adapt78).

Amber N Mitchell1, Lalithapriya Jayakumar, Issam Koleilat, Jiang Qian, Christine Sheehan, Dipti Bhoiwala, Shazneen F Hushmendy, Janet M Heuring, Dana R Crawford.   

Abstract

RCAN1 (Adapt78) is an endogenous inhibitor of calcineurin, an important intracellular phosphatase that mediates many cellular responses to calcium. RCAN1 is expressed in multiple organs, especially heart, skeletal muscle and brain. In brain, it is thought to be important due to its strong expression, developmental regulation, abundance of target protein (calcineurin), and putative links to multiple brain-related disorders. Surprisingly, however, few studies have examined RCAN1 protein expression here. This has led to some confusion in the field over the exact nature and cell-type expression of isoform 4, the more studied of the two major RCAN1 protein isoforms, in brain. Here we characterize RCAN1 brain isoforms in more detail by assessing their size and distribution under conditions of calcium elevation, a hallmark of the isoform 4 response, and using rodent models to allow for more expanded analyses. We find that the 25-29kDa version of this protein, reported in many non-brain studies, is indeed also present in neurons, and most observable after calcium induction. We also observe that expression of isoform 4 is not specific to neurons, as both microglia and astrocyte cells in culture exhibit a strong induction of isoform 4 protein following calcium stress that is not observable in non-stressed tissue sections. Isoform 1 expression is also observable in a primary glial cell-type (rat microglia). Finally, our observations confirm previous reports of low or non-detectable constitutive isoform expression in non-stressed glia, and of a larger sized, RCAN1 antibody-interacting species. These studies extend and complement previous studies on RCAN isoforms toward better understanding the role of RCAN1 in brain function and as a potential new target for treating calcineurin-related brain disorders.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17910944     DOI: 10.1016/j.abb.2007.08.030

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  9 in total

1.  Immunotherapy of cerebrovascular amyloidosis in a transgenic mouse model.

Authors:  Veronica Lifshitz; Ronen Weiss; Tali Benromano; Einat Kfir; Tamar Blumenfeld-Katzir; Catherine Tempel-Brami; Yaniv Assaf; Weiming Xia; Tony Wyss-Coray; Howard L Weiner; Dan Frenkel
Journal:  Neurobiol Aging       Date:  2011-03-02       Impact factor: 4.673

2.  Secretion of Down Syndrome Critical Region 1 Isoform 4 in Ischemic Retinal Ganglion Cells Displays Anti-Angiogenic Properties Via NFATc1-Dependent Pathway.

Authors:  Yue Xu; Boyu Yang; Yaguang Hu; Lin Lu; Xi Lu; Jiawei Wang; Qinmeng Shu; Qiaochu Cheng; Shanshan Yu; Fan Xu; Jingjing Huang; Xiaoling Liang
Journal:  Mol Neurobiol       Date:  2016-10-12       Impact factor: 5.590

3.  Amyloid-β toxicity and tau hyperphosphorylation are linked via RCAN1 in Alzheimer's disease.

Authors:  Ana Lloret; Mari-Carmen Badia; Esther Giraldo; Gennady Ermak; Maria-Dolores Alonso; Federico V Pallardó; Kelvin J A Davies; Jose Viña
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

4.  Behavioral characterization of a mouse model overexpressing DSCR1/ RCAN1.

Authors:  Mara Dierssen; Gloria Arqué; Jerome McDonald; Nuria Andreu; Carmen Martínez-Cué; Jesús Flórez; Cristina Fillat
Journal:  PLoS One       Date:  2011-02-25       Impact factor: 3.240

Review 5.  Calcineurin Signalling in Astrocytes: From Pathology to Physiology and Control of Neuronal Functions.

Authors:  Dmitry Lim; Laura Tapella; Giulia Dematteis; Maria Talmon; Armando A Genazzani
Journal:  Neurochem Res       Date:  2022-09-09       Impact factor: 4.414

Review 6.  The regulator of calcineurin (RCAN1) an important factor involved in atherosclerosis and cardiovascular diseases development.

Authors:  E Torac; L Gaman; V Atanasiu
Journal:  J Med Life       Date:  2014 Oct-Dec

Review 7.  The Emerging Roles of the Calcineurin-Nuclear Factor of Activated T-Lymphocytes Pathway in Nervous System Functions and Diseases.

Authors:  Maulilio John Kipanyula; Wahabu Hamisi Kimaro; Paul F Seke Etet
Journal:  J Aging Res       Date:  2016-08-15

8.  Altered expression of insulin-degrading enzyme and regulator of calcineurin in the rat intracerebral streptozotocin model and human apolipoprotein E-ε4-associated Alzheimer's disease.

Authors:  Büşra Delikkaya; Natalia Moriel; Ming Tong; Gina Gallucci; Suzanne M de la Monte
Journal:  Alzheimers Dement (Amst)       Date:  2019-05-15

Review 9.  Why antidiabetic drugs are potentially neuroprotective during the Sars-CoV-2 pandemic: The focus on astroglial UPR and calcium-binding proteins.

Authors:  Carlos-Alberto Gonçalves; Patrícia Sesterheim; Krista M Wartchow; Larissa Daniele Bobermin; Guilhian Leipnitz; André Quincozes-Santos
Journal:  Front Cell Neurosci       Date:  2022-07-29       Impact factor: 6.147

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.